Related Experiment Video
Updated: Sep 17, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Innovations in randomized clinical trials in Nephrology: from study design to patient's activism
Giuseppe Pezzi1, Roberta Arena2, Giuliana Papalia2
1Department of Medical and Surgical Sciences, Magna Graecia University of Catanzaro, 88100 Catanzaro, Italy.
Abstract:
Current clinical practice is guided by novel robust evidence from randomized clinical trials (RCT). These studies usually follow a rigorous prospective design with pre-defined visits and planned exams during follow-up. In the context of Nephrology, RCTs have been mainly designed to test the efficacy of new therapies in reducing the risk for kidney failure, estimated Glomerular Filtration Rate decline and mortality or cardiovascular events. However, the progress of informatics is reflected in an improvement and expansion of technologies and innovations in present and future RCTs. We here present some innovations and future directions of RCTs in Chronic Kidney Disease patients.
Insights
Randomized clinical trials (RCTs) in nephrology are evolving with informatics advancements. Future kidney disease research will incorporate new technologies to improve trial design and patient outcomes.
Area of Science:
- Nephrology
- Clinical Trials
- Health Informatics
Background:
- Randomized clinical trials (RCTs) are crucial for evidence-based clinical practice.
- Traditional RCTs in nephrology focus on kidney failure, GFR decline, mortality, and cardiovascular events.
- Advancements in informatics are transforming the design and execution of clinical trials.
Purpose of the Study:
- To present innovations and future directions for RCTs in Chronic Kidney Disease (CKD) patients.
- To highlight how informatics can enhance CKD clinical trial methodologies.
- To discuss the integration of new technologies in nephrology research.
Main Methods:
- Review of current practices in nephrology RCTs.
- Exploration of informatics-driven innovations.
- Discussion of future trends in CKD clinical trial design.
Main Results:
- Informatics offers opportunities to improve RCT efficiency and data collection.
- New technologies can lead to more personalized and adaptive trial designs.
- Future RCTs in CKD will likely leverage digital health tools and big data.
Conclusions:
- Informatics integration is essential for advancing nephrology research.
- Innovations in RCTs promise more effective evaluation of CKD therapies.
- The future of CKD trials lies in embracing technological advancements for better patient care.
More Related Videos
14:43A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
04:53A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Blinding
Chronic Kidney Disease III: Interprofessional Care